Results 231 to 240 of about 192,408 (300)

Monlunabant in adults with obesity and metabolic syndrome: Open‐label extension of a phase 2a trial

open access: yes
Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4366-4371, May 2026.
Filip K. Knop   +10 more
wiley   +1 more source

Neuropsychiatric Outcomes of IL‐17 and IL‐23 Inhibitors in Dermatology: Risks, Benefits, and Clinical Implications

open access: yes
International Journal of Dermatology, Volume 65, Issue 5, Page 1108-1111, May 2026.
Isabella J. Tan   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy